Bloomage BioTechnology Corporation Limited (SHA:688363)
China flag China · Delayed Price · Currency is CNY
47.18
+2.35 (5.24%)
At close: Feb 2, 2026

SHA:688363 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
728.48719.271,1691,6061,8071,390
Trading Asset Securities
-30.02140.04530.72846.89722.7
Cash & Short-Term Investments
728.48749.291,3092,1372,6542,113
Cash Growth
34.52%-42.75%-38.75%-19.47%25.58%-29.62%
Accounts Receivable
551.43547.38450.19457.87402.22388.99
Other Receivables
39.0145.2739.4251.9128.934.7
Receivables
590.44592.65489.61509.78431.12423.69
Inventory
1,1231,2481,1351,162709.13476.77
Other Current Assets
157.58150.96189.99214.93190.37650.11
Total Current Assets
2,6002,7413,1234,0233,9843,664
Property, Plant & Equipment
4,0354,2033,6572,9132,3051,258
Long-Term Investments
470.72585.02502.99592.63400.3217.9
Goodwill
181.61174.09251.28247.2267.1574.64
Other Intangible Assets
516.33490.63496.97475.06467.26426.74
Long-Term Deferred Tax Assets
346.82355.56336.98302.59246.1193
Long-Term Deferred Charges
107.78100.3498.14116.4331.8515.64
Other Long-Term Assets
210.947.513.6311.51.44167.32
Total Assets
8,4698,6578,4708,6827,5045,717
Accounts Payable
621.56195.41186.78247.75243.55119.08
Accrued Expenses
100.45587.09479.49672.75704.09236.64
Short-Term Debt
50.0349.92-139.2-24.08
Current Portion of Long-Term Debt
88.4728.89106.0836.5436.46-
Current Portion of Leases
-62.7947.0553.6749.61-
Current Income Taxes Payable
54.9913.8555.6876.43135.5250.91
Current Unearned Revenue
66.8763.4855.5867.7450.8343.4
Other Current Liabilities
57.94339.6290.13349.97180.4678.77
Total Current Liabilities
1,0401,3411,2211,6441,401552.87
Long-Term Debt
58.7565.122.32107.97144.18-
Long-Term Leases
34.98152.9752.6652.4269.77-
Long-Term Unearned Revenue
239.84253.24205.73188.68182.71141.35
Long-Term Deferred Tax Liabilities
5.414.575.095.664.124.54
Total Liabilities
1,3791,8171,4871,9991,801698.76
Common Stock
481.68481.68481.68481.09480480
Additional Paid-In Capital
3,8563,8533,8413,7533,5693,452
Retained Earnings
2,9002,7002,7082,4091,6741,088
Treasury Stock
-219.95-219.95-105.88---
Comprehensive Income & Other
42.28-4.3219.57-9.1-23.91-0.01
Total Common Equity
7,0606,8106,9446,6345,6995,020
Minority Interest
30.3629.6339.3349.213.45-1.62
Shareholders' Equity
7,0906,8406,9836,6835,7025,018
Total Liabilities & Equity
8,4698,6578,4708,6827,5045,717
Total Debt
232.24359.69208.1389.79300.0124.08
Net Cash (Debt)
496.24389.61,1011,7472,3542,089
Net Cash Growth
107.18%-64.60%-37.00%-25.77%12.67%-30.42%
Net Cash Per Share
1.020.802.283.624.874.37
Filing Date Shares Outstanding
478.36478.36480.26481.09480480
Total Common Shares Outstanding
478.36478.36480.26481.09480480
Working Capital
1,5601,4001,9022,3792,5843,111
Book Value Per Share
14.7614.2414.4613.7911.8710.46
Tangible Book Value
6,3626,1456,1965,9115,1654,518
Tangible Book Value Per Share
13.3012.8512.9012.2910.769.41
Buildings
-2,4961,7561,3851,269458.14
Machinery
-1,7941,4101,148812.35495.06
Construction In Progress
-640.981,109830.45516.72618.11
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.